Literature DB >> 10028950

The renin-angiotensin system and its receptors.

U Stroth1, T Unger.   

Abstract

The renin-angiotensin system (RAS) plays an important role in blood pressure control and in water and salt homeostasis. It is involved in the pathophysiology of hypertension and structural alterations of the vasculature, kidney, and heart, including neointima formation, nephrosclerosis, postinfarction remodeling, and cardiac left ventricular hypertrophy (LVH). Recently, an increased knowledge of the effector peptides of the RAS, their receptors, and their respective functions has led to a new principle of treatment for hypertension: the inhibition of angiotensin (Ang) II via angiotensin-converting enzyme inhibitors or Ang II-receptor antagonists. In this review, the Ang receptors AT1 and AT2 and the potential roles of shorter angiotensin fragments, including Ang III(2-8), Ang IV(3-8), and Ang(1-7), are discussed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10028950     DOI: 10.1097/00005344-199900001-00005

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  21 in total

Review 1.  Marfan syndrome. Part 2: treatment and management of patients.

Authors:  Victoria Cañadas; Isidre Vilacosta; Isidoro Bruna; Valentin Fuster
Journal:  Nat Rev Cardiol       Date:  2010-03-30       Impact factor: 32.419

2.  Molecular mechanisms of inherited thoracic aortic disease - from gene variant to surgical aneurysm.

Authors:  Elizabeth Robertson; Candice Dilworth; Yaxin Lu; Brett Hambly; Richmond Jeremy
Journal:  Biophys Rev       Date:  2014-12-06

3.  Interactions between atrial natriuretic peptide and the renin-angiotensin system during salt-sensitivity exhibited by the proANP gene-disrupted mouse.

Authors:  Ekaterini Angelis; M Yat Tse; Stephen C Pang
Journal:  Mol Cell Biochem       Date:  2005-08       Impact factor: 3.396

4.  Timing of captopril administration determines radiation protection or radiation sensitization in a murine model of total body irradiation.

Authors:  Thomas A Davis; Michael R Landauer; Steven R Mog; Michal Barshishat-Kupper; Stephen R Zins; Mihret F Amare; Regina M Day
Journal:  Exp Hematol       Date:  2010-01-29       Impact factor: 3.084

Review 5.  Association between angiotensin I-converting enzyme gene polymorphism and susceptibility to cancer: a meta analysis.

Authors:  Kan Zhang; Dan Cheng; Lingling Yi; Huimin Shi; Guohua Zhen
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

6.  Active immunization with angiotensin I peptide analogue vaccines selectively reduces the pressor effects of exogenous angiotensin I in conscious rats.

Authors:  S M Gardiner; T R Auton; M R Downham; H L Sharp; P A Kemp; J E March; H Martin; P J Morgan; A Rushton; T Bennett; J F Glover
Journal:  Br J Pharmacol       Date:  2000-03       Impact factor: 8.739

7.  Angiotensin-converting enzyme gene DD genotype neither increases susceptibility to acute pancreatitis nor influences disease severity.

Authors:  Nevin Oruc; Georgios I Papachristou; Haritha Avula; Adam Slivka; Janette Lamb; David C Whitcomb
Journal:  HPB (Oxford)       Date:  2009-02       Impact factor: 3.647

Review 8.  Angiotensin II dose-effect curves and Schild regression plots for characterization of different angiotensin II AT1 receptor antagonists in clinical pharmacology.

Authors:  Gustav G Belz
Journal:  Br J Clin Pharmacol       Date:  2003-07       Impact factor: 4.335

9.  AT(2) receptor-dependent vasodilation is mediated by activation of vascular kinin generation under flow conditions.

Authors:  Jun Katada; Masataka Majima
Journal:  Br J Pharmacol       Date:  2002-06       Impact factor: 8.739

Review 10.  ACE2, a promising therapeutic target for pulmonary hypertension.

Authors:  Vinayak Shenoy; Yanfei Qi; Michael J Katovich; Mohan K Raizada
Journal:  Curr Opin Pharmacol       Date:  2011-01-05       Impact factor: 5.547

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.